Pantoprazol Kalceks (Pantoprazole)

Pantoprazol Kalceks is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining.
• Erosive oesophagitis: heals erosive lesions and prevents recurrence.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Helicobacter pylori eradication regimens (as adjunct): enhances ulcer healing when used with antibiotics.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly lowers gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Pantoprazol Kalceks may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: watery stools without blood.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild cramping.
• Flatulence: increased intestinal gas.
• Constipation: infrequent, hard stools.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty.
• Clostridioides difficile infection: persistent diarrhoea with abdominal pain.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Liver enzyme elevation: abnormal liver function tests.
• Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider the following safety measures:

• Assess renal function: dose adjustment may be required in severe impairment.
• Review concomitant medications: potential for interaction with drugs that need gastric acidity.
• Monitor electrolytes: especially magnesium during prolonged therapy.
• Evaluate bone health: consider calcium/vitamin D supplementation if long‑term use is anticipated.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole can affect the absorption and metabolism of several medicines. Clinical monitoring is advised.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): markedly reduced absorption.
• HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.
• Clopidogrel: reduced antiplatelet effect, consider alternative therapy.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, monitor coagulation.
• Methotrexate: reduced renal clearance, watch for toxicity.
• Digoxin: modest increase in serum levels, assess cardiac status.
• Iron salts and certain vitamins: decreased absorption, separate dosing by at least 2 hours.